Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
Cathelicidin is Critical for Pathogenic T cell Development in Multiple Sclerosis
Gwyer Findlay, Emily
(Principal Investigator)
Deanery of Clinical Sciences
University of Edinburgh
Overview
Fingerprint
Research output
(4)
Research output
Research output per year
2019
2019
2021
2021
3
Article
1
Review article
Research output per year
Research output per year
3 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Article
Search results
2021
The Outcome of Neutrophil-T Cell Contact Differs Depending on Activation Status of Both Cell Types
Minns, D.
,
Smith, K. J.
,
Hardisty, G.
,
Rossi, A. G.
&
Gwyer Findlay, E.
,
30 Mar 2021
,
In:
Frontiers in Immunology.
12
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Neutrophil
100%
T Cell
100%
Cell Contact
100%
T Cell Proliferation
20%
Cell Proliferation
20%
The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation
Minns, D.
,
Smith, K. J.
,
Alessandrini, V.
,
Hardisty, G.
,
Melrose, L.
,
Jackson-Jones, L.
,
MacDonald, A. S.
,
Davidson, D. J.
&
Gwyer Findlay, E. L.
,
24 Feb 2021
,
In:
Nature Communications.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Polypeptide Antibiotic Agent
100%
Neutrophil
100%
Cathelicidin
100%
Antimicrobial Peptides
100%
T Cell
14%
2019
Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
Findlay, E. G.
,
Currie, A. J.
,
Zhang, A.
,
Ovciarikova, J.
,
Young, L.
,
Stevens, H.
,
McHugh, B. J.
,
Canel, M.
,
Gray, M.
,
Milling, S. W. F.
,
Campbell, J. D. M.
,
Savill, J.
,
Serrels, A.
&
Davidson, D. J.
,
1 May 2019
, (E-pub ahead of print)
In:
OncoImmunology.
p. 1-17
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Dendritic Cell
100%
Antimicrobial Peptides
100%
Immunotherapy
100%
Cytotoxic T-Cell
20%
T-Helper Cell
20%